← Back
$STOK All transactions

Stoke Therapeutics, Inc.

▼ SELL

$ Value

$1K

Shares

37

Price

$33

Filed

Mar 19

Insider

Name

Leggett Thomas

Title

Chief Financial Officer

CIK

0001774690

Roles

Officer

Transaction Details

Transaction Date

2026-03-18

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

10,172

Footnotes

The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive.

Filing Info

Accession No.

0001774690-26-000006

Form Type

4

Issuer CIK

0001623526

Leggett Thomas's History

Date Ticker Type Value
2026-03-18 STOK $68K
2026-03-18 STOK $5K
2026-03-18 STOK $1K
2026-03-17 STOK $42K
2026-03-17 STOK $31K
2026-03-15 STOK M $0
2026-03-15 STOK M $0
2026-02-17 STOK A $0
2026-02-17 STOK A $0

Other Insiders at STOK (90d)

Insider Bought Sold Last
LEVIN ARTHUR A $22K 2026-03-13
SMITH IAN F
Chief Executive Officer
2026-02-17
Kaye Edward M. MD 2026-03-15
TZIANABOS ARTHUR
Interim Executive Chair
$174K 2026-03-10
Hoitt Jason
Chief Patient Officer
$119K 2026-03-18
Leggett Thomas
Chief Financial Officer
$146K 2026-03-18
Krainer Adrian R. $1.6M 2026-03-10
Ticho Barry
CHIEF MEDICAL OFFICER
$517K 2026-04-01
Kahn Clare 2026-04-03
Allan Jonathan
GENERAL COUNSEL & CORP SEC
$599K 2026-03-20